首页> 外文会议>IFAC Symposium on Biological and Medical Systems >Reducing the Length of Mechanical Ventilation with Significance: A Case Study of Sample Size Estimation Trial Design Using Monte-Carlo Simulation
【24h】

Reducing the Length of Mechanical Ventilation with Significance: A Case Study of Sample Size Estimation Trial Design Using Monte-Carlo Simulation

机译:利用蒙特卡罗模拟减少了具有重要意义的机械通风的长度:使用Monte-Carlo仿真进行样本量估计试验设计

获取原文

摘要

The power of a study can be established with estimation of total effective sample size (N_(total)). In this study, the impact of the length of mechanical ventilation (LoMV) distribution shape in intensive care on the estimated N_(total) is investigated. This study provides an overview on the study design involving LoMV, the resulting potential limitations, and the criteria for a 'successful' design. Data from mechanical ventilated patients in a single-center intensive care unit were used in this study. The N_(total) was estimated using two methods: 1) Model-based Altman's nomogram (a standard); and 2) Monte-Carlo simulation. Using Monte-Carlo simulation, a patient selection criteria is imposed to estimate N_(total) from 'realistic' patient cohorts. The Altman nomogram shows that the N_(total) to detect a 25% change in LoMV (ALoMV) at power of 0.8 is ≥1000 patients. For the Monte-Carlo simulation, a N_(total) ≥260 patients is needed to detect similar changes. It is important to consider the LoMV distribution shape and variability, particularly relative to target patient groups who might benefit from the intervention. Assessment of ALoMV in response to treatment should be carefully considered to avoid an under-powered studies. The Monte-Carlo simulation combined with objective patient selection provides better design of such studies.
机译:可以通过估计总有效样本大小(N_(总))来建立研究的力量。在这项研究中,研究了机械通风长度(LOMV)分布形状在估计的N_(总计)上的重症监护的影响。本研究概述了涉及LOMV,由此产生的潜在限制以及“成功”设计的标准的研究设计。本研究中使用了来自单中心重症监护单元中机械通风患者的数据。使用两种方法估计N_(总计):1)基于模型的Altman的拓图(标准); 2)Monte-Carlo仿真。使用Monte-Carlo仿真,施加患者选择标准,以估计“逼真”患者队列的N_(总计)。 Altman Nom图表明,N_(总计)检测LOMV(ALOMV)的25%变化为0.8的功率为≥1000名患者。对于Monte-Carlo仿真,需要N_(总计)≥260名患者来检测类似的变化。重要的是要考虑LOMV分布形状和可变性,特别是相对于可能从干预中受益的目标患者团体。应仔细考虑对治疗响应的alOMV评估,以避免受通量的研究。 Monte-Carlo仿真与客观患者选择相结合,提供了更好的这些研究设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号